Product Description
Product details
- Packaging Size : 25 tablets in 1 strip
- Deals in : GSK
- Prescription/Non prescription : Prescription
- Treatment : In Ovarian cancer
- Manufacturer : Glaxo SmithKline Pharmaceuticals Ltd
- Composition : Melphalan (2mg)
- Brand : Glaxo SmithKline Pharmaceuticals Ltd
Careful Preparation and HandlingAlkeran 50mg for injection must be dissolved with the included diluent before use, following strict cytotoxic protocols. Healthcare professionals should wear protective equipment and handle the glass vial with caution, ensuring that preparation occurs in a controlled environment to minimize exposure risks.
Optimal Storage and Shelf LifeThe product requires storage below 30C, away from direct light. The reconstituted solution should be used immediately or as directed, preserving efficacy and safety. Alkeran's shelf life extends up to 36 months, ensuring reliable supply for hospitals, clinics, and pharmacies.
FAQ's of Alkeran components for melphalan injeetion 50mg:
Q: How should Alkeran 50mg lyophilized powder be reconstituted before intravenous injection?
A: To prepare Alkeran for intravenous use, dissolve the white to off-white lyophilized powder with the supplied diluent. Always use protective equipment during reconstitution to ensure cytotoxic safety and follow the instructions provided in the pack.
Q: What is the primary medical use of Alkeran 50mg, and who is it indicated for?
A: Alkeran is indicated for the treatment of multiple myeloma and ovarian carcinoma. It is prescribed exclusively by healthcare professionals and should only be administered by individuals trained in cytotoxic chemotherapy.
Q: When and how should the reconstituted Alkeran solution be administered?
A: After proper reconstitution, the solution should be administered intravenously, preferably immediately after preparation. If immediate use is not possible, follow the specific storage and handling directions to maintain product stability.
Q: Where can I find the batch number and expiry date for Alkeran 50mg?
A: Both the batch number and expiry date are clearly printed on the carton packaging, enabling tracking for safety, efficacy, and regulatory compliance.
Q: What precautions are recommended for handling and disposing of Alkeran vials?
A: Given its cytotoxic nature, handling Alkeran requires gloves, protective clothing, and strict adherence to hazardous drug protocols. Dispose of used vials and consumables according to local hazardous waste regulations.
Q: What are the main components of Alkeran 50mg lyophilized powder for injection?
A: Each vial contains melphalan 50mg and mannitol as the inactive powder ingredient. The provided diluent contains propylene glycol and ethanol to ensure proper dissolution and solubility.